The purpose of this study is to determine the safety and clinical outcomes of the Absorb BVS for daily use in patients with de novo lesions in previously untreated vessels.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Acute Success: Device success (lesion based analysis)
Timeframe: From the start of index procedure to end of index procedure
Acute Success: Procedural success (patient based analysis)
Timeframe: From the start of index procedure to end of index procedure
Death (Cardiovascular, Non-Cardiovascular)
Timeframe: 1 year
Death (Cardiovascular, Non-Cardiovascular)
Timeframe: 3 year
Myocardial Infarction (MI)
Timeframe: 1 year
MI
Timeframe: 3 year
Target Lesion Revascularization (TLR)
Timeframe: 1 year
TLR
Timeframe: 3 year
TLR
Timeframe: 1 year
TLR
Timeframe: 3 year
Target Vessel Revascularization (TVR)
Timeframe: 1 year
TVR
Timeframe: 3 year
TVR
Timeframe: 1 year
TVR
Timeframe: 3 year
Cardiac Death/TV-MI/ID-TLR (Target Lesion Failure (TLF)) (Device-oriented endpoint)
Timeframe: 1 year
Cardiac Death/TV-MI/ID-TLR (Target Lesion Failure (TLF)) (Device-oriented endpoint)
Timeframe: 3 year
Cardiac Death/All MI/ID-TLR (MACE)
Timeframe: 1 year
Cardiac Death/All MI/ID-TLR (MACE)
Timeframe: 3 year
Cardiac Death/All MI/ID-TVR (Target Vessel Failure (TVF))
Timeframe: 1 year
Cardiac Death/All MI/ID-TVR (Target Vessel Failure (TVF))
Timeframe: 3 year
Scaffold/Stent Thrombosis
Timeframe: 1 year
Scaffold/Stent Thrombosis
Timeframe: 1 year
Scaffold/Stent Thrombosis
Timeframe: 3 year
Scaffold/Stent Thrombosis
Timeframe: 3 year